On Tuesday, Cogent Biosciences Inc (NASDAQ: COGT) was -6.75% drop from the session before settling in for the closing price of $8.00. A 52-week range for COGT has been $5.73 – $12.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -41.25%. When this article was written, the company’s average yearly earnings per share was at -0.39%. With a float of $92.00 million, this company’s outstanding shares have now reached $110.46 million.
Let’s determine the extent of company efficiency that accounts for 164 employees. In terms of profitability, gross margin is 47.39%, operating margin of -4660.58%, and the pretax margin is -4336.02%.
Cogent Biosciences Inc (COGT) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cogent Biosciences Inc stocks. The insider ownership of Cogent Biosciences Inc is 16.72%, while institutional ownership is 94.61%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.60% during the next five years compared to 15.33% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
You can see what Cogent Biosciences Inc (COGT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.48, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -2.33 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Looking closely at Cogent Biosciences Inc (NASDAQ: COGT), its last 5-days average volume was 0.85 million, which is a drop from its year-to-date volume of 1.42 million. As of the previous 9 days, the stock’s Stochastic %D was 8.98%. Additionally, its Average True Range was 0.49.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 14.31%, which indicates a significant increase from 0.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.38% in the past 14 days, which was lower than the 58.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.30, while its 200-day Moving Average is $9.28. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $7.82. Second resistance stands at $8.19. The third major resistance level sits at $8.37. If the price goes on to break the first support level at $7.27, it is likely to go to the next support level at $7.09. Should the price break the second support level, the third support level stands at $6.72.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are 110,462K outstanding shares of the company, which has a market capitalization of 824.04 million. As of now, sales total 0 K while income totals -192,410 K. Its latest quarter income was 0 K while its last quarter net income were -70,630 K.
